Teva Pharmaceutical Industries
TEVA
#633
Rank
A$56.24 B
Marketcap
A$48.29
Share price
-0.32%
Change (1 day)
81.92%
Change (1 year)

Teva Pharmaceutical Industries (TEVA) - Cash on Hand

Cash on Hand as of December 2025 : A$5.01 Billion

According to Teva Pharmaceutical Industries's latest financial reports the company has A$5.01 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Teva Pharmaceutical Industries - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$5.30 B0.07%
2024-12-31A$5.30 B12.05%
2023-12-31A$4.73 B15.04%
2022-12-31A$4.11 B37.83%
2021-12-31A$2.98 B5.48%
2020-12-31A$2.83 B0.37%
2019-12-31A$2.82 B11.52%
2018-12-31A$2.52 B105.07%
2017-12-31A$1.23 B-10.01%
2016-12-31A$1.37 B-85.62%
2015-12-31A$9.53 B250.55%
2014-12-31A$2.71 B133.73%
2013-12-31A$1.16 B-58%
2012-12-31A$2.77 B159.18%
2011-12-31A$1.06 B-15.44%
2010-12-31A$1.26 B-49.49%
2009-12-31A$2.50 B-7.42%
2008-12-31A$2.70 B-17.8%
2007-12-31A$3.28 B26.82%
2006-12-31A$2.59 B-14.23%
2005-12-31A$3.02 B124.73%
2004-12-31A$1.34 B-27.51%
2003-12-31A$1.85 B-0.01%
2002-12-31A$1.85 B19.87%
2001-12-31A$1.54 B103.9%
2000-12-31A$0.75 B428.53%
1999-12-31A$0.14 B78.79%
1998-12-31A$80.35 M-10.67%
1997-12-31A$89.94 M3.26%
1996-12-31A$87.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
A$16.27 B 224.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$21.14 B 321.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$14.74 B 193.92%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$25.70 B 412.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$8.10 B 61.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$6.27 B 24.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Dr. Reddy's Laboratories
RDY
A$1.29 B-74.13%๐Ÿ‡ฎ๐Ÿ‡ณ India